← Leaderboards
Maggie Chasse
Van Andel Research Institute
$535,640
Attributed
$535,640
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $114.5K · FY2019–24$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$535,640 · 3
By mechanism
K00$408,639 · 1
F31$80,981 · 1
F99$46,020 · 1
Top collaborators
No co-investigators on record.
Most similar at Van Andel Research Institute
Same institution · by research overlap
- Sara A Courtneidge$12,091,658
- Darren John Moore$10,901,167
- H Eric Xu$10,075,813
- Wei Lu$8,697,930
- Cynthia K Miranti$3,405,241
Others in their field
Other Emerging Leaders on “Rhabdoid Tumor”
- Raushan Kurmasheva · University Of Texas Hlth Science Center$2,024,146
- April M. Weissmiller · Middle Tennessee State University$549,836
- Todd C Hankinson · University Of Colorado Denver$233,250
- Timothy Mulvihill · University Of Utah$167,804
- Sandi Radko-Juettner · St. Jude Children'S Research Hospital Graduate School Of Biomedical Sciences, Llc$87,288
- Seamus Balinth · Cold Spring Harbor Laboratory$75,520
Research focus
Rhabdoid TumorTumorIn VivoPlicamycinTherapeutic TargetTranscription FactorFrequenciesHistone DemethylaseMalignant Childhood NeoplasmPenetranceSmarcb1 GeneSomatic MutationCombined Modality TherapyComplexEffective TherapyEpigenetic ProcessAutomobile DrivingGenetic TranscriptionCellsChromatin Remodeling FactorMalignant NeoplasmsMutationSmall MoleculeCareer
Grant awards (7)
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors$114,533
K00 · FY2024 · CA · contact PI
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors$101,606
K00 · FY2023 · CA · contact PI
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors$96,956
K00 · FY2022 · CA · contact PI
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors$95,544
K00 · FY2021 · CA · contact PI
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors$46,020
F99 · FY2020 · CA · contact PI
Development of Mithramycin Analogues to Target Transcriptional Vulnerabilities in Rhabdoid Tumor$36,965
F31 · FY2020 · CA · contact PI
Development of Mithramycin Analogues to Target Transcriptional Vulnerabilities in Rhabdoid Tumor$44,016
F31 · FY2019 · CA · contact PI